I just met with this company on my recent trip to China and wrote about it last week. I still like it moving forward, as it is going after the packaged-tour market in China, and the country's domestic tourism business -- let alone the international one -- is set to boom over the next decade. Since I wrote about the stock in late December, it is down 4.7% vs. the S&P's 6.8% gain.
A provider of nutritional supplements, including ones for traditional Chinese medicine, CSKI has dropped 27% since my pick. I've learned that the company doesn't have any Chinese-language version of its website. To a large extent, it exists only for the US investor market. I would avoid it moving forward.
The stock has been on a tear since I picked it -- up 94% this quarter. I like the company and its Chinese organic fertilizer business. I recently met with the company's COO. The problem is valuation -- it's a bit frothy right now. I would wait before getting in.
I'm still a big believer in this coking-coal company, which is gaining ownership of more and more coal mines in the Shanxi province of China. The stock is up 77% since my suggestion and just got upgraded last week. There are still good times ahead.
Fuqi International (FUQI - commentary -Trade Now) The stock had a high-profile stumble when it delayed filing its 10K. News last week suggested the company would file it soon, which breathed new life into the stock. Still, it's down 29% since my recommendation. Assuming it cleans up its books, the stock is in a great space as a middle-market Chinese jeweler.
So, some hits and misses in this group. However, if you had taken an equally weighted position in all five stocks, the portfolio would have returned 22%, or triple the return of the S&P 500 over that period.